Watson Inventory Reserves Reflect Delayed Launch Of Wellbutrin SR Generics
Executive Summary
Watson is taking an inventory reserve to account for the delayed launch of its "authorized" generic of GlaxoSmithKline's Wellbutrin SR (bupropion sustained-release)